檢索結果 - Andrew Wisniewski
- Showing 1 - 3 results of 3
-
1
-
2
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease 由 Jacques Cosnes, Harry Sokol, Anne Bourrier, Isabelle Nion–Larmurier, Andrew Wisniewski, Cécilia Landman, Philippe Marteau, Laurent Beaugerie, Katherine K. Perez, Philippe Seksik
出版 2016Artigo -
3
Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines 由 Andrew Wisniewski, Julien Kirchgesner, Philippe Seksik, Cécilia Landman, Anne Bourrier, Isabelle Nion‐Larmurier, Philippe Marteau, Jacques Cosnes, Harry Sokol, Laurent Beaugerie, Lionel Arrivé, Laurent Beaugerie, Anne Bourrier, Marine Camus, Najim Chafaı̈, Edouard Chambenois, Ulriikka Chaput, Clotilde Debove, Charlotte Delattre, Xavier Dray, Jean–François Fléjou, Guillaume Le Gall, Nadia Hoyeau, Julien Kirchgesner, Cécilia Landman, Jérémie H. Lefèvre, Philippe Marteau, Chloé Martineau, Laurence Monnier‐Cholley, Isabelle Nion‐Larmurier, Violaine Ozenne, Yann Parc, Philippe Seksik, Harry Sokol, Magali Svrcek, Emmanuel Tiret
出版 2019Artigo
相關主題
Disease
Internal medicine
Medicine
Environmental health
Gastroenterology
Incidence (geometry)
Inflammatory bowel disease
Optics
Physics
Population
Adalimumab
Adenocarcinoma
Anal Carcinoma
Anal canal
Biology
Cancer
Cohort
Confidence interval
Context (archaeology)
Crohn's disease
Hazard ratio
Immunology
Infliximab
Odds ratio
Paleontology
Proportional hazards model
Rectum
Retrospective cohort study
Surgery